These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23690769)

  • 1. Sarcopenic obesity and endocrinal adaptation with age.
    Sakuma K; Yamaguchi A
    Int J Endocrinol; 2013; 2013():204164. PubMed ID: 23690769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of skeletal muscle mass and fat mass on the metabolic and inflammatory profile in sarcopenic and non-sarcopenic overfat elderly.
    Rossi FE; Lira FS; Silva BSA; Freire APCF; Ramos EMC; Gobbo LA
    Aging Clin Exp Res; 2019 May; 31(5):629-635. PubMed ID: 30178443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise Therapy for People With Sarcopenic Obesity: Myokines and Adipokines as Effective Actors.
    Alizadeh Pahlavani H
    Front Endocrinol (Lausanne); 2022; 13():811751. PubMed ID: 35250869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A moderate intensity exercise program improves physical function and oxidative damage in older women with and without sarcopenic obesity.
    Gutiérrez-López L; Olivares-Corichi IM; Martínez-Arellanes LY; Mejía-Muñoz E; Polanco-Fierro JA; García-Sánchez JR
    Exp Gerontol; 2021 Jul; 150():111360. PubMed ID: 33878422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenic obesity.
    Polyzos SA; Margioris AN
    Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project.
    Hirani V; Naganathan V; Blyth F; Le Couteur DG; Seibel MJ; Waite LM; Handelsman DJ; Cumming RG
    Age Ageing; 2017 May; 46(3):413-420. PubMed ID: 27932368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenic obesity: a new category of obesity in the elderly.
    Zamboni M; Mazzali G; Fantin F; Rossi A; Di Francesco V
    Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):388-95. PubMed ID: 18395429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The prevalence of sarcopenic obesity in postmenopausal women in depending on the used methodology - preliminary study].
    Milewska M; Sińska B; Sych D; Kucharska A
    Pol Merkur Lekarski; 2015 Apr; 38(226):206-10. PubMed ID: 25938387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
    Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review.
    Goisser S; Kemmler W; Porzel S; Volkert D; Sieber CC; Bollheimer LC; Freiberger E
    Clin Interv Aging; 2015; 10():1267-82. PubMed ID: 26346071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention.
    Li CW; Yu K; Shyh-Chang N; Li GX; Jiang LJ; Yu SL; Xu LY; Liu RJ; Guo ZJ; Xie HY; Li RR; Ying J; Li K; Li DJ
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):586-600. PubMed ID: 30969486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and sarcopenic obesity.
    Choi KM
    Korean J Intern Med; 2016 Nov; 31(6):1054-1060. PubMed ID: 27809450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
    Lee J; Hong YP; Shin HJ; Lee W
    J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
    McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
    BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.
    Batsis JA; Villareal DT
    Nat Rev Endocrinol; 2018 Sep; 14(9):513-537. PubMed ID: 30065268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Consequences of Sarcopenic Obesity: A Narrative Review.
    Roh E; Choi KM
    Front Endocrinol (Lausanne); 2020; 11():332. PubMed ID: 32508753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
    Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
    Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
    Consitt LA; Clark BC
    J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin in sarcopenic visceral obesity: possible link between adipocytes and myocytes.
    Kohara K; Ochi M; Tabara Y; Nagai T; Igase M; Miki T
    PLoS One; 2011; 6(9):e24633. PubMed ID: 21931785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.